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Mitochondrial dynamicsThe molecular mechanisms underlying striatal vulnerability in Huntington's disease (HD) are still unknown.
However, growing evidence suggest thatmitochondrial dysfunction could play amajor role. In searching for a po-
tential link between striatal neurodegeneration and mitochondrial defects we focused on cyclin-dependent ki-
nase 5 (Cdk5). Here, we demonstrate that increased mitochondrial ﬁssion in mutant huntingtin striatal cells
can be a consequence of Cdk5-mediated alterations in Drp1 subcellular distribution and activity since pharmaco-
logical or genetic inhibition of Cdk5 normalizes Drp1 function ameliorating mitochondrial fragmentation. Inter-
estingly, mitochondrial defects in mutant huntingtin striatal cells can be worsened by D1 receptor activation a
process also mediated by Cdk5 as down-regulation of Cdk5 activity abrogates the increase in mitochondrial ﬁs-
sion, the translocation of Drp1 to themitochondria and the raise of Drp1 activity induced by dopaminergic stim-
ulation. In sum, we have demonstrated a new role for Cdk5 in HD pathology by mediating dopaminergic
neurotoxicity through modulation of Drp1-induced mitochondrial fragmentation, which underscores the
relevance for pharmacologic interference of Cdk5 signaling to prevent or ameliorate striatal neurodegeneration
in HD.
© 2015 Elsevier B.V. All rights reserved.1. Materials and methods
1.1. Cell cultures
Conditionally immortalized wild-type ST7/7Q and mutant ST111/
111Q striatal neuronal progenitor cell lines expressing endogenous
levels of normal and mutant huntingtin with 7 and 111 glutamines,
respectively, have been described previously [1]. Striatal cells were
grown at 33 °C in Dulbecco's modiﬁed Eagle's medium (DMEM,
Sigma-Aldrich; St. Louis,MO,USA), supplementedwith 10% fetal bovine
serum, 1% penicillin–streptomycin, 2 mM L-glutamine, 1 mM sodium
pyruvate and 400 μg/ml G418 (Geneticin; GIBCO-BRL, Life technologies;
Gaithersburg, MD, USA).
1.2. Primary cultures of mouse striatal neurons
Dissociated striatal cultures prepared from E.18 Hdh7/7Q and Hdh7/
111Q embryos were plated at a density of 40,000 neurons onto 24-well
plates pre-coated with 0.1mg/ml poly-D-lysine (Sigma Chemical Co., St.
Louis, MO). Neurons were cultured in Neurobasal medium (Gibco-BRL,
Renfrewshire, Scotland, UK), supplemented with B27 (Gibco-BRL) andsanova 143, E-08036 Barcelona,GlutamaxTM (Gibco-BRL). Cultures were maintained at 37 °C in a
humidiﬁed atmosphere containing 5% CO2.
1.3. HD mouse models
HdhQ111 knock-in mice, with targeted insertion of 109 CAG repeats
that extends the glutamine segment in murine huntingtin to 111 resi-
dues, were maintained on a C57BL/6 genetic background. Male and fe-
male Hdh7/111Q heterozygous mice were intercrossed to generate
age-matched Hdh7/111Q heterozygous and Hdh7/7Q wild-type litter-
mates. The animals were housed with access to food and water ad
libitum in a colony room kept at 19–22 °C and 40–60% humidity,
under a 12:12 h light/dark cycle. Only males were used to perform all
the experiments. All procedures were performed in compliance with
the National Institutes of Health Guide for the Care and Use of Laborato-
ry Animals, and approved by the local animal care committee of
the Universitat de Barcelona (99/01) and Generalitat de Catalunya
(00/1094), in accordance with the Directive 2010/63/EU of the
European Commission.
1.4. Drug treatment
To assess the effect of dopamine receptor activation onmitochondri-
al population, striatal cell lines were treated as previously described [2].
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serumdepleted (2.5% FBS) for 24 h and then exposed to Locke's solution
(154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl2, 3.6 mM NaHCO3, 5 mM
HEPES, 5.6 mM glucose, and 10 μM glycine) for 30 min before the addi-
tion of SKF 38393, 30 or 60 μM (Sigma Aldrich) in fresh DMEMmedium
(2.5% FBS). To prevent SKF 38393 effect, cultures were treated with the
D1 receptor antagonist SCH 23390 10 μM(SigmaAldrich) 1 h before SKF
38393 treatments. Total extracts were obtained 60min after SKF 38393
treatment for later analysis. To inhibit Cdk5 activity, cultureswere treat-
ed with the Cdk5 inhibitor roscovitine, 20 μM (Sigma-Aldrich) 1 h be-
fore SKF 38393 treatments. Cells were then ﬁxed for later analysis.
1.5. Cell transfection
Cells were transiently transfected using Lipofectamine 2000
(Invitrogen, Life Technologies) according to themanufacturer's instruc-
tions and incubated for 48 h before use. To suppress Cdk5 expression,
cells were transfected with the appropriate antisense oligonucleotides
(sc-35047; Santa Cruz Biotechnology, Santa Cruz, CA) or with a scram-
ble control (sc-37007; Santa Cruz Biotechnology) and harvested
for Western blot or ﬁxed for immunocytochemistry analysis 48 h
post-transfection.
1.6. Subcellular fractionation
Mitochondria from cell lines have been isolated as described by Yang
and colleagues [3] with slight modiﬁcations. Brieﬂy, wild-type ST7/7Q
and mutant ST111/111Q cells were washed twice, harvested in ice
cold phosphate-buffered saline (PBS; 140 mM NaCl, 2 mM KCl, 1.5
KH2PO4, 8 mM NaH2PO4, pH 7.4) and resuspended in isolation buffer
(IB; 250 mM sucrose, 20 mM HEPES-KOH pH 7.5, 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA) with protease and phosphatase inhibitors
(0.1 mM phenylmethylsulfonyl ﬂuoride, 1 mM sodium orthovanadate,
10 mg/ml aprotinin and 10 mg/ml leupeptin). Cells were homogenized
with aDounce homogenizer and the suspensionwas then centrifuged at
800 ×g for 10 min at 4 °C to remove nuclei and unbroken cells. The su-
pernatantswere centrifuged again at 10,000×g for 20min at 4 °C to pel-
let the heavy membrane fractions containing mitochondria. The pellet
fraction was washed, spun down again at 10,000 ×g, resuspended in
IB containing 1% Triton X-100 and ﬁnally saved at−80 °C for later anal-
ysis. The cytosolic fraction was obtained as supernatants by further
centrifugation at 16,000 ×g for 20 min at 4 °C to remove residual mito-
chondria and saved at−80 °C for later analysis.
1.7. Western blot analysis
Total cellular extracts were collected in lysis buffer containing
50 mM Tris base, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.1 mM
phenylmethylsulfonyl ﬂuoride, 1% NP-40, and supplemented with
1 mM sodium orthovanadate and protease inhibitor mixture (Sigma-
Aldrich). Sampleswere centrifuged at 10,000×g for 10min and the pro-
tein contents determined by Detergent-Compatible Protein Assay (Bio-
Rad, Hercules, CA, USA). For the analysis of the striatum of Hdh mice,
heterozygous mutant Hdh7/111Q and wild type Hdh7/7Q mice were
killed by cervical dislocation at the age of 8 months. The brain was
quickly removed, dissected, frozen in dry ice and stored at −80 °C
until use. Protein extraction from striatal tissue and Western blot anal-
ysis were performed as previously described [4]. Protein extracts
(10–20 μg)weremixedwith 5×-SDS sample buffer, boiled for 5min, re-
solved on 8–10% SDS-PAGE, and transferred to nitrocellulose mem-
branes (Whatman Schleicher & Schuell, Keene, NH, USA). Blots were
blocked in 10% non-fat powdered milk in Tris-buffered saline Tween-
20 (TBS-T; 50 mM Tris-HCl, 150 mM NaCl, pH 7.4, 0.05% Tween 20)
for 60 min at room temperature. The membranes were then incubated
overnight at 4 °Cwith primary antibodies: Drp1 (DLP1; 1:1000; BD Bio-
science, San Jose, CA, USA), phospho-Drp1 (S616) (1:1000, CellSignaling Technology, Beverly, MA, USA), OPA1 (1:8000, BD Biosci-
ence), Mfn2 (1:2000, Abcam, Cambridge, UK), and Cdk5 J-3 (1:1000,
Santa Cruz Biotechnology). Loading control was performed by reprov-
ing the membranes with anti-tubulin (1:50,000, Sigma Aldrich) or
anti-actin (1:20,000; MP Biochemicals, Irvine, CA, USA) and with anti-
OxPhos Complex V (CoxV; 1:3000; Molecular Probes Inc., Eugene, OR,
USA) for mitochondrial fractions. The membranes were then rinsed
three times with TBS-T and incubated with horseradish peroxidase-
conjugated secondary antibody (1:3000; Promega Madison, WI, USA)
for 1 h at room temperature. After washing for 30 min with TBS-T, the
membranes were developed using the enhanced chemiluminescence
ECL kit (Santa Cruz Biotechnology). The intensity of immunoreactive
bands was quantiﬁed by using Image J software (National Institutes of
Health, Bethesda, MD, USA). Data are expressed as the mean ± SEM
of band density.
1.8. Immunocytochemistry and confocal analysis
Striatal cells were ﬁxed in 4% paraformaldehyde (ElectronMicrosco-
py Science EMS, Hatﬁeld, PA, USA) for 10 min, rinsed in PBS, treated
with 0.1 M Glycine for 20 min, and then permeabilized in 0.1% saponin
for 10 min. Blocking was done in 1% bovine serum albumin in
phosphate-buffered saline for 1 h. Specimens were incubated with pri-
mary antibody TOM20 (1:250, Santa Cruz Biotechnology) for 2 h at
room temperature. Thereafter, sampleswere incubatedwith the follow-
ing secondary antibodies: AlexaFluo 488 anti-rabbit (1:100; Jackson
Immunoresearch, West Grove, PA) and Phalloidin-conjugated with
TRITC (1:1000, Sigma Chemicals). Nuclei were stainedwith theHoechst
33258 (1:10,000,Molecular Probes, Life Technologies) for 5min. For de-
tection of D1 receptor on cell surface, the permeabilizationwith saponin
was omitted and samples were incubated with primary antibody anti-
Dopamine Receptor D1 (1:500, Abcam) overnight. Afterwards, samples
were incubated with the secondary antibody AlexaFluo 488 anti-rabbit
(1:100; Jackson Immunoresearch). For immunocytochemical experi-
ments in primary cultures, eight days after plating, neurons were ﬁxed
with 4% PFA/phosphate buffer for 10 min, rinsed in PBS, blocked in
PBS containing 0.1 M glycine for 10 min and permeabilized in PBS con-
taining 0.1% saponin for 10 min and blocked in PBS containing Normal
Horse Serum 15% for 30 min at room temperature. Neurons were then
washed in PBS and incubated overnight at 4 °C with primary antibodies
TOM20 (1:250, Santa Cruz Biotechnology) and MAP2 (1:500, Sigma-
Aldrich) and detected with AlexaFluo 488 anti-rabbit and Cy3 anti-
mouse secondary antibodies (1:100, Jackson ImmunoResearch). As
negative controls, some neurons were processed as described in the
absence of primary antibody and no signal was detected. Nuclei were
stained with the Hoechst 33258 (1:10,000, Molecular Probes, Life Tech-
nologies) for 5 min. Stained cells and neurons were then washed twice
with PBS andmounted under glass coverslipswithMowiol. Immunoﬂu-
orescence was analyzed by confocal microscopy using a Leica TCS SP5
laser scanning spectral confocal microscope (Leica Microsystems Hei-
delberg GmbH). Confocal images were taken using a 63× numerical ap-
erture objective with a 3× digital zoom and standard pinhole. For each
cell, the entire three-dimensional stack of images from the ventral sur-
face to the top of the cell was obtained by using the Z drive in the Leica
TCS SP5 microscope. The size of the optical image was 0.4 μm.
1.9. Analysis of mitochondrial morphology
Quantitative analyses ofmitochondrialmorphologywere performed
as previously described [5,6]. Brieﬂy, digital images were processed
through a convolve ﬁlter to obtain isolated and equalized ﬂuorescent
pixels and then to a thresholding step using the NIH-developed ImageJ
software (National Institutes of Health, Bethesda, MD). This procedure
yields a binary image containing black mitochondrial structures on a
white background (Supplementary Fig. 1). From this binary image, indi-
vidual mitochondria (particles) were subjected to particle analyses to
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tochondrial outline and Am is the area of mitochondrion) and Aspect
Ratio values (AR, the ratio between the major and minor axis of the el-
lipse equivalent to the mitochondrion) as well as the number of mito-
chondria per cell. An AR value of 1 indicates a perfect circle, and as
mitochondria elongate and become more elliptical, AR increases. A FF
value of 1 corresponds to a circular, unbranched mitochondrion, and
higher FF values indicate increase of mitochondrial complexity (length
and branching). For determination of the percentage of cells with
fragmented mitochondria, a cell was determined to have fragmented
mitochondria if it had ≥50% of its mitochondria with length/width
(axis) ratios b2.5. In average 25–30 cells/genotype were analyzed
from 3 to 6 independent experiments. For the analysis in neurons, the
number of mitochondria per micron of axon was measured using NIH
ImageJ software.
1.10. Drp1 immunoprecipitation and GTPase enzymatic activity assay
Wild-type ST7/7Q and mutant ST111/111Q cells were washed with
cold PBS and incubated on ice in lysis buffer (20 mM Tris [pH 7.5], 0.6%
CHAPS, 10% glycerol, 1mM sodium orthovanadate and protease inhibitor
cocktail) for 15 min. Cells were scraped and then disrupted 10 times by
repeated aspiration through a 25-gauge needle. Samples were centri-
fuged at 10,000 ×g for 10 min and the supernatant was saved as the
whole cell extract. To determine GTPase activity of Drp1, a total of
400 μg of whole-cell extract was immunoprecipitated overnight with
25 μg of anti-Drp1 antibody (BD Bioscience) and 40 μl of protein A/G-
agarose (Santa Cruz Biotechnology). For the analysis of Drp1 enzymatic
activity in Hdh mice, frozen striatal tissues from heterozygous mutant
Hdh7/111Q and wild type Hdh7/7Q mice at the age of 8 months were
washed with cold PBS and incubated on ice in lysis buffer (20 mM Tris
[pH 7.5], 0,6% CHAPS, 10% glycerol, 1mM sodiumorthovanadate and pro-
tease inhibitor cocktail) for 15 min. Tissue was homogenized with a
Dounce homogenizer and the lysate was centrifuged at 10,000 ×g for
10min and the supernatant was saved as thewhole tissue extract. To de-
termine GTPase activity of Drp1, a total of 400 μg of whole-tissue extract
was immunoprecipitated overnight with 25 μg of anti-Drp1 antibody (BD
Bioscience) and 40 μl of protein A/G-agarose (Santa Cruz Biotechnology).
GTPase activity of the protein was determined using a GTPase assay kit
(Novus Biologicals, Littleton, CO, USA) according to manufacturer's in-
structions. After three washes with lysis buffer and three washes with
GTPase buffer (50 mM Tris [pH 7.5], 2.5 mM MgCl2, and 0.02% 2-
mercaptoethanol), the beads were incubated with 0.5 mM GTP at 30 °C
for 1 h. Drp1 hydrolyzes GTP to GDP and inorganic phosphorous (Pi)
and we measured GTPase activity, based on the amount of inorganic
phosphorous that the GTP produces. By adding the ColorLock Gold
(orange) substrate to the inorganic phosphorous that is generated from
GTP, we assessed GTP activity, based on the inorganic complex solution
(green). Colorimetric measurements (green) were read in the wave-
length range of 650 nm using a Synergy 2Multi-ModeMicroplate Reader
(BioTek Instruments, Inc.; Winooski, VT, USA).
1.11. Real-time quantitative RT-PCR
Total RNAwas isolated from thewild-type ST7/7Q andmutant knock-
in ST111/111Q striatal cell lines using the total RNA isolation Nucleospin
RNA II Kit (Macherey-Nagel). Puriﬁed RNA (500 ng) was reverse tran-
scribed using the PrimeScript RT Reagent Kit (Perfect Real Time, Takara
Biotechnology Inc.). The cDNA synthesis was performed at 37 °C for
15min and a ﬁnal step at 85 °C for 5 s in a ﬁnal volume of 20 μl according
to the manufacturer's instructions. The cDNA was then analyzed by
quantitative RT-PCR using the following PrimeTime qPCR Assays
(Integrated DNA Technologies, Inc.): Dnm1l (Mm.PT.56a.16160059);
18S (Hs.PT.39a.22214856.g) and Actinβ (Mm.PT.39a.22214843.g). RT-
PCR was performed in 12 μl of ﬁnal volume on 96-well plates using the
Premix Ex Taq (Probe qPCR) (TAKARA BIOTECHNOLOGY (Dalian) Co.,LTD). Reactions included Segment 1:1 cycle of 30 s at 95 °C and Segment
2: 40 cycles of 5 s at 95 °C and 20 s at 60 °C. All quantitative PCR assays
were performed in duplicate. To provide negative controls and exclude
contamination by genomic DNA, the PrimeScript RTEnzymewas omitted
in the cDNA synthesis step. The quantitative PCR data were quantiﬁed
using the comparative quantitation analysis program of MxProTM quan-
titative PCR analysis software version 3.0 (Stratagene) using 18S and
Actinβ gene expression as housekeeping genes.
1.12. Statistical analysis
All the data were analyzed with the program GraphPad Prism ver-
sion 5.0a (Graph Pad Software). Results are expressed as mean ±
SEM. Unpaired Student's t-test for differences between two groups or
One-way ANOVA followed by the post hoc Newman–Keuls multiple
comparison test were used to assess signiﬁcance (p b 0.05), as indicated
in ﬁgure legends.
2. Introduction
Huntington's disease (HD) is an autosomal-dominant inherited neu-
rodegenerative disorder, characterized by progressive behavioral, motor
and cognitive deﬁcits [7,8]. The predominant neuropathological hallmark
of HD is the selective loss of medium spiny neurons within the striatum
that extends to other brain regions with the progression of the disease
[9]. Although mutant huntingtin (mHtt) represents a key factor in the
pathogenesis of the disease, the molecular mechanisms underlying the
preferential vulnerability of the striatum tomHtt toxicity remain unclear.
From last years, compelling evidence argues in favor of a role ofmitochon-
drial dysfunction in HD neuropathology [10–12]. Thus, the expression of
mHtt leads to deﬁcits in energymetabolism [13], alterations inmitochon-
drial calciumhandling [14,15] and severe changes inmitochondrial struc-
ture integrity [16,17]. However, given the ubiquitous expression of mHtt
within the brain other factors should contribute to alter mitochondrial
function in the striatum. One hypothesis is that dopamine (DA), which
is present at high concentrations in the striatum compared to other
brain areas, might increase the sensitivity of mitochondria to mHtt toxic-
ity inducing mitochondrial dysfunction and neurodegeneration. Actually,
by using primary striatal cultures expressing the N-terminal mHtt frag-
ment it has been reported that DA acting via D2 receptors reduces the
levels of themitochondrial Complex II (mCII) increasing the vulnerability
of striatal cells to mHtt-induced cell death [18]. Besides D2 receptors, we
and others have also demonstrated a critical role for D1 receptors in
striatal neurodegeneration inHD [2,19]. Thus, we reported that activation
of D1 receptors induces an increase in the susceptibility of mutant
huntingtin striatal cells to cell death, an effect that was mediated by
Cyclin-dependent kinase-5 (Cdk5) [2]. Importantly, Cdk5 has been iden-
tiﬁed as an upstream kinase that regulates mitochondrial ﬁssion during
neuronal apoptosis while its suppression attenuates apoptotic mitochon-
drial fragmentation [20,21]. In this view, we hypothesized that the
increased susceptibility of mutant huntingtin striatal cells to D1R activa-
tion could be mediated by Cdk5-induced disturbances in mitochondrial
function. To validate this theory we used precise genetic HD models ex-
pressing endogenous levels of full-length wild-type ormutant huntingtin
[1,2]. Our results reveal a new role for Cdk5 in HD pathology by playing a
key role in regulating mitochondrial ﬁssion events involved in striatal
neurodegeneration and highlight Cdk5 as a therapeutic target to treatmi-
tochondrial dysfunction in HD and other neurodegenerative disorders.
3. Results
3.1. Mutant ST111/111Q striatal cells exhibit aberrant mitochondrial
dynamics
Abnormalities in mitochondrial morphology and dynamics have
been reported in HD as early pathological events [22–24]. To determine
A ST7/7Q
ST111/111Q
B D
C E
Fig. 1. ST111/111Q mutant cells show increased mitochondrial fragmentation.
(A) Representative confocal images showing mitochondrial morphology in wild-type
ST7/7Q and mutant ST111/111Q cells immunostained with anti-TOM20 (green), anti-
Phalloidin-TRITC (red) and Hoechst stain (blue); scale bar 20 μm. The boxed areas are en-
larged in the panels on the right; scale bar 2 μm. (B, C) Bar histogram showing the Aspect
Ratio (AR) and Form Factor (FF) value. *p b 0.05 as determined by unpaired Student's t-
test. (D) Bar histogram showing the number of mitochondria per cell. *p b 0.05 as deter-
mined by unpaired Student's t-test. (E) Bar histogram showing the percentage of cells
with fragmented mitochondria relative to the total number of cells. **p b 0.01 as deter-
mined by unpaired Student's t-test. Data represent mean ± SEM of 6 independent exper-
iments in which 25–30 cells/genotype were analyzed with ImageJ software.
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model, wild-type ST7/7Q and mutant ST111/111Q huntingtin striatal
cells were stainedwith TOM20 and phalloidin andmitochondrial popu-
lation was analyzed by confocal microscopy (Fig. 1A). Morphometric
analysis revealed that mutant ST111/111Q striatal cells display signiﬁ-
cant differences in the mitochondrial morphology compared to wild-
type ST7/7Q cells. Thus, the values of the Aspect Ratio (AR) and
Form factor (FF) demonstrated reduced mitochondrial length (~10%
decrease; p b 0.05. Fig. 1B) and lowermitochondrial complexity and de-
creased branching (~14%; p b 0.05. Fig. 1C), respectively. These alter-
ations correlated in mutant cells with a signiﬁcant increase in the
number of mitochondria per cell (~15%; p b 0.01. Fig. 1D) Moreover,
when the percentage of cell population showing mitochondrial frag-
mentation was analyzed more than 40% of mutant ST111/111Q striatal
cells exhibited fragmentedmitochondriawhereas only 20% ofwild-type
ST7/7Q cells showed this mitochondrial ﬁssion morphology (p b 0.01;
Fig. 1E). Altogether, these ﬁndings suggest a toxic effect of mHtt on mi-
tochondrial dynamics.
3.2. Mutant huntingtin deregulates the levels and activity of mitochondrial
ﬁssion/fusion proteins in ST111/111Q striatal cells
Changes inmitochondrial morphology depend on the balance of op-
posing ﬁssion and fusion events [25]. Interestingly, mHtt has been re-
ported to induce changes in the expression of different pro-ﬁssion and
pro-fusion mitochondrial proteins [26]. To understand the molecular
basis of the observed abnormal mitochondrial fragmentation we deter-
mined the levels of mitochondria-shaping proteins in our striatal cell
lines by Western blot analysis (Fig. 2). No signiﬁcant differences in the
total levels of the fusion protein Opa1 were observed between geno-
types (Fig. 2A). However, when the mitochondrial fraction was ana-
lyzed, mutant ST111/111Q cells displayed signiﬁcantly lower levels
of Opa1 compared to those in wild-type ST7/7Q cells (20% decrease;
p b 0.05). Next the levels of another essential ﬁssion protein, Mfn2
were investigated. No signiﬁcant changes either between subcellular
fractions or between genotypes were observed (Supplementary
Fig. 2). Surprisingly, we also found a signiﬁcant decrease (30% decrease;
p b 0.05. Fig. 2B) in the total levels of the ﬁssion protein Drp1 in mutant
compared to wild-type striatal cells, a reduction that was even higher
when mitochondrial subcellular fractions were evaluated (50% de-
crease; p b 0.01)without changes in the cytosolic fraction. To determine
if this decrease was due to altered gene transcription, Drp1 mRNA ex-
pression was evaluated. A statistically signiﬁcant decrease in Drp1
mRNA levels was detected in mutant ST111/111Q compared to wild-
type ST7/7Q striatal cells (20% decrease; p b 0.05. Fig. 2C) suggesting
an involvement of mHtt in the transcriptional deregulation of Drp1.
SincemHtt abnormally interacts with Drp1 altering its structure and in-
creasing its enzymatic activity [27], we then evaluated Drp1-GTPase ac-
tivity in striatal cells (Fig. 2D). Despite the low levels of Drp1 expression
found in mutant huntingtin cells, a signiﬁcant increase (~3.5-fold
increase; p b 0.01. Fig. 2D) in the GTP-binding activity of Drp1 was ob-
served inmutant compared towild-type cells suggesting that enhanced
mitochondrial fragmentation in mutant huntingtin cells could be relat-
ed with higher Drp1 activity.
3.3. Hdh7/111Q knock-in mutant mice display impaired mitochondrial
dynamics and increased Drp1 activity
To extend our mitochondrial ﬁndings in an in vivo HD model, we
next analyzed whether alterations in mitochondrial dynamics were
also detected in primary striatal neurons from Hdh7/111Q knock-in
mutantmice. Confocalmicroscopy analysis (Fig. 3A) revealed thatmito-
chondria from mutant Hdh7/111Q primary striatal neurons were more
fragmented with respect to those in wild-type Hdh7/7Q mice (~30%;
p b 0.05. Fig. 3B). Considering that abnormalities in the morphology
and function of mitochondria persist along the disease progression[17], alterations in the levels of the ﬁssion protein Drp1 were analyzed
in the striatum of Hdh7/111Q knock-in mutant mice at 8 months of
age. Immunoblot analysis revealed no changes in striatal Drp1 protein
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Fig. 2. ST111/111Qmutant cells exhibit altered expression, subcellular distribution and activity of Drp1. (A, B) RepresentativeWestern blots showing the levels of the fusion protein Opa1
in total and mitochondrial fractions and the ﬁssion protein Drp1 in total, cytosolic andmitochondrial fractions fromwild-type ST7/7Q andmutant ST111/111Q cells.α-Tubulin (total and
cytosol) or CoxV (mitochondria) were used as loading controls. Letters confer to the different isoforms recognized by the respective antibodies (L-Opa1 and S-Opa-1; DRP1: a–b). Bar his-
tograms indicate the relative fold change± SEM of 9 independent experiments; **p b 0.01, *p b 0.05 vs. wild-type ST7/7Q cells as determined by unpaired Student's t-test. (C) Histogram
showing Drp1 mRNA expression analyzed by RT-PCR in wild-type ST7/7Q and mutant ST111/111Q cells. Data were normalized to 18S and actinβ gene expression. Bar histogram repre-
sents the relative fold change± SEM of 7 independent experiments. *p b 0.05 vs. wild-type ST7/7Q cells as determined by unpaired Student's t-test. (D) Histogram showing GTPase Drp1
enzymatic activity in striatal extracts obtained fromwild-type ST7/7Q andmutant ST111/111Q cells. Bar diagram represents the relative fold change±SEMof 5 independent experiments.
**p b 0.01 vs. wild-type ST7/7Q cells as determined by unpaired Student's t-test.
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of the subcellular fractions analyzed (Fig. 3C). However and in agree-
ment with our results in mutant ST111/111Q striatal cells, theenzymatic activity of Drp1 was signiﬁcantly increased (~2-fold
increase; p b 0.05. Fig. 3D) in mutant Hdh7/111Q mice compared
to wild-type Hdh7/7Q mice. These data support the idea that
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Total fractions Cytosolic fractionsC
D
Hdh7/7Q Hdh7/111Q Hdh7/7Q Hdh7/111Q
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Fig. 3.Mutant Hdh7/111Q mice exhibit impaired mitochondrial fragmentation associated with increased Drp1 activity. (A, B) Representative confocal images of striatal primary culture
from wild-type Hdh7/7Q and mutant Hdh7/111Q mice immunostained with anti-TOM20 (green) and anti-MAP2 (red); scale bar 20 μm. The boxed areas are enlarged in the panels on
the bottom; scale bar 4 μm. The bar graph provides the percentage of mitochondria per axonal micron. Data represent mean ± SEM of 4 independent experiments in which 20
neurons/genotype were analyzed with ImageJ software; *p b 0.05 vs. wild-type Hdh7/7Q mice as determined by unpaired Student's t-test. (C) Representative Western blots showing
the levels of the ﬁssion protein Drp1 in total, cytosolic and mitochondrial fractions obtained from the striatum of wild-type Hdh7/7Q and mutant Hdh7/111Q mice. α-Tubulin
(total and cytosol) or CoxV (mitochondria)were used as loading controls. Bar histograms indicate the relative levels of Drp1±SEMof 7 independent experiments. (D) Histogram showing
GTPaseDrp1enzymatic activity in striatal extracts obtained from8-month-oldwild-typeHdh7/7Q andmutantHdh7/111Qmice. Bar histogram indicates the relative fold change±SEMof
6 independent experiments; *p b 0.05 vs. Hdh7/7Q as determined by unpaired Student's t-test.
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Fig. 4. Aberrant Cdk5 activity in ST111/111Q mutant cells induces mitochondrial fragmentation. (A, E) Representative confocal images showing mitochondrial morphology in wild-type
ST7/7Q andmutant ST111/111Q cells treatedwith roscovitine (20 μM). Cellswere stainedwith anti-TOM20 (green), anti-Phalloidin-TRITC (red) andHoechst stain (blue); scale bar 20 μm.
Panels on the right show enlargement of the boxed areas; scale bar 2 μm. Bar histograms showing: (B, F) the relative Form Factor (FF) value, (C, G) the percentage of number ofmitochon-
dria per cell and (D, H) the percentage of cells with fragmentedmitochondria relative to the total number of cells. Data representmean± SEMof 5 independent experiments inwhich 25–
30 cells/condition were analyzed with ImageJ software. *p b 0.05 vs. vehicle treated condition as determined by unpaired Student's t-test. (I) Histogram showing GTPase Drp1 enzymatic
activity in striatal extracts obtained from vehicle or roscovitine treated wild-type ST7/7Q and mutant ST111/111Q cells. Bar histogram indicates the relative fold change ±SEM of 4
independent experiments; **p b 0.01 vs. wild-type ST7/7Q cells and #p b 0.05 vs. vehicle-treated ST111/111Q cells as determined byOne-way ANOVAwith Newman–Keuls post hoc anal-
ysis. (L) Histogram showingDrp1mRNA expression analyzed by RT-PCR inwild-type ST7/7Q andmutant ST111/111Q cells transfectedwith siRNA or siCdk5. Datawere normalized to 18S
and actinβ gene expression. Bar histogram indicates the relative fold change ± SEM of 7 independent experiments. ***p b 0.001 and **p b 0.01 vs. siRNA transfected ST7/7Q cells as
determined by One-way ANOVA with Newman–Keuls post hoc analysis.
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Fig. 5. Dopaminergic D1 receptor activation increases mitochondrial ﬁssion events and mitochondrial branching defects in striatal cells. (A) Representative confocal images showing mi-
tochondrial morphology in wild-type ST7/7Q and mutant ST111/111Q cells treated with vehicle or the dopaminergic agonist SKF 38393 (60 μM). Cells were stained with anti-TOM20
(green), anti-Phalloidin-TRITC (red) and Hoechst stain (blue); scale bar 20 μm. Last panels on the right show enlargement of the boxed areas; scale bar 2 μm. (B, C) Bar histograms
showing mitochondrial size by Aspect Ratio (AR) values and mitochondrial branching changes determined by the analysis of the Form Factor (FF) value in SKF 38393-treated and
vehicle-treated wild-type ST7/7Q and mutant ST111/111Q cells. Data represent mean ± SEM of 6 independent experiments in which 25–30 cells/condition were analyzed with ImageJ
software. ***p b 0.001, *p b 0.05 vs. vehicle-treated ST7/7Q cells and #p b 0.05 vs. vehicle-treated ST111/111Q cells as determined by One-way ANOVA with Newman–Keuls post hoc
analysis. (D) Bar histogram showing percentage of number of mitochondria per cell. (E) Bar histogram showing the percentage of vehicle or SKF 38393-treatedwild-type ST7/7Q andmu-
tant ST111/111Q cells with fragmentedmitochondria relative to the total number of cells. Data representmean± SEMof 6 independent experiments inwhich 25–30 cells/conditionwere
analyzed with ImageJ software. ***p b 0.001, **p b 0.01 and *p b 0.05 vs. vehicle-treated ST7/7Q cells and ##p b 0.01 and #p b 0.05 vs. vehicle-treated ST111/111Q cells as determined by
one-way ANOVA with Newman–Keuls post hoc analysis.
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Drp1 enzymatic activity induced by mHtt.
3.4. Cdk5 contributes to Drp1-induced mitochondrial dysfunction in
mutant ST111/111Q striatal cells
Cdk5 may promote mitochondrial dysfunction [28] acting as an up-
stream regulator of mitochondrial ﬁssion during neuronal apoptosisTubulin
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Fig. 6. Aberrant mitochondrial Drp1 activity exacerbates D1R-induced mitochondrial ﬁssion in
fusion protein Opa1 in total andmitochondrial fractions and the ﬁssion protein Drp1 in total, cy
wild-type ST7/7Q andmutant ST111/111Q cells.α-Tubulin (total and cytosol) or CoxV (mitocho
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Drp1 enzymatic activity in striatal extracts obtained from vehicle or SKF 38393-treated mutan
independent experiments; **p b 0.01 vs. vehicle-treated ST7/7Q cells, #p b 0.05 vs. vehicle tre
One-way ANOVA with Newman–Keuls post hoc analysis.[21]. Since we have previously demonstrated an aberrant increase
in Cdk5 activity inmutant ST111/111Q cells [2] we next aimed to deter-
mine the relevance of Cdk5 inmitochondrial ﬁssion.Wild-type ST7/7Q
(Fig. 4A) and mutant ST111/111Q cells (Fig. 4E) were treated with
the Cdk5 inhibitor roscovitine and mitochondrial morphology was
analyzed by confocal microscopy. Roscovitine treatment signiﬁ-
cantly improved mitochondrial tubular network defects (~10%
increase in the Form Factor value; p b 0.05. Fig. 4F) and reducedMitochondrial fractions
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e fold change± SEM of 12 independent experiments. ***p b 0.001, **p b 0.01, *p b 0.05 vs.
y One-way ANOVAwith Newman–Keuls post hoc analysis. (C) Histogram showing GTPase
t ST111/111Q striatal cells. Bar histogram represents the relative fold change ± SEM of 6
ated ST111/111Q cells and §p b 0.05 vs. SKF 38393 treated ST7/7Q cells as determined by
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mutant but not wild-type huntingtin cells (Fig. 4A–D) suggesting
an important role of Cdk5 in mitochondrial dysfunction in HD
striatal cells. Since we have demonstrated increased Drp1 activity
in mutant huntingtin striatal cells, we next addressed whether
the improvement in mitochondrial fragmentation following
roscovitine treatment was associated with a reduction in Drp1 ac-
tivity. According to a role of Cdk5 in mitochondrial impairments,
pharmacological inhibition of Cdk5 signiﬁcantly reduced (~50%
decrease; p b 0.01. Fig. 4I) Drp1 activity in mutant ST111/111Q
cells without any effect in wild-type ST7/7Q cells. Interestingly, we
also found that in addition to Drp1 activity Drp1 gene transcription
was also modulated by Cdk5. Thus, a signiﬁcant decrease in Drp1
mRNA expression was observed in wild-type (~40% decrease;
p b 0.01) and mutant (~70% decrease; p b 0.001) huntingtin striatal
cells when expression of Cdk5 was reduced by Cdk5 siRNAs (Fig. 4L)
revealing a critical role for Cdk5 as a transcriptional regulator of
Drp1.3.5. Activation of dopaminergic D1 receptors increases mitochondrial
dysfunction in mutant ST111/111Q striatal cells
We have previously demonstrated that mutant ST111/111Q
cells are more susceptible to cell death induced by D1R activation
than wild-type ST7/7Q cells [2]. Interestingly, it has been reported
that dopamine could negatively inﬂuence mitochondrial function
[29,30]. Therefore, to determine whether the enhanced vulnerabil-
ity of mutant ST111/111Q cells to dopamine-induced cell death
was mediated by mitochondrial impairments wild-type ST7/7Q
and mutant ST111/111Q cells were treated with the D1 receptor
agonist SKF 38393 (60 μM) and mitochondrial morphology was an-
alyzed by confocal microscopy (Fig. 5A). First, we analyze whether
these striatal cells properly express D1R at the plasma membrane
(Supplementary Fig. 3). Cell surface D1R expression examined
with an antibody against the extracellular domain of D1R in non-
permeable cell conditions was similar between wild type and mu-
tant huntingtin striatal cells. Then mitochondrial ﬁssion was exam-
ined. Our ﬁndings demonstrated that mitochondrial fragmentation
occurs quickly in response to D1 receptor activation leading to a
signiﬁcant decrease in the size (Fig. 5B) and mitochondrial reticu-
lar network distribution (Fig. 5C) in both cell genotypes. It is
important to notice that dopaminergic stimulation was able to
further decrease FF and AR values in mutant huntingtin cells com-
pared to vehicle conditions (~10%; p b 0.05). The alterations in mi-
tochondrial morphology induced by SKF 38393 treatment were
also detected by an increase in the number of organelles per cell
(Fig. 5D) showing both genotypes an increment of 20% (p b 0.05;
Fig. 5E) compared to vehicle conditions. Finally, when the percent-
age of cells with mitochondrial fragmentation was analyzed, we
found that, in wild-type cells D1R activation raised the percentage
from 20% to 40% (p b 0.05 Fig. 5E) while the transition in mutant cells
was from 50% to 80% (p b 0.01). These mitochondrial alterations were
dose-dependent since the treatment with lower concentration of
SKF 38393 (30 μM) did not alter mitochondrial conformation in
both cell types (Supplementary Fig. 4). Finally, to validate that SKF
38393 effects on mitochondria morphology were D1R-dependent,
wild-type and mutant huntingtin striatal cells were treated with
the D1R antagonist SCH 23390 prior to D1R activation and mito-
chondrial ﬁssion was analyzed (Supplementary Fig. 5). Importantly,
co-incubation with SCH 23390 completely abrogates SKF 38393-
induced alterations in mitochondrial morphology in both cell geno-
types. Overall these results indicate that the increased susceptibility
of mutant huntingtin striatal cells to dopaminergic activation could
bemediated by alterations in the distribution andmorphology of the
mitochondrial population.3.6. Activation of dopaminergic D1 receptors alters the levels, distribution
and activity of the ﬁssion protein Drp1 in ST111/111Q striatal cells
Confocal microscopy analysis has shown that SKF 38393 treatment
induces higher mitochondrial fragmentation in mutant compared to
wild-type huntingtin cells. To correlate this morphological alterations
with changes in mitochondrial ﬁssion/fusion proteins, the levels of
Opa1 andDrp1were analyzed in total, cytosolic andmitochondrial frac-
tions obtained from vehicle and SKF 38393 treated wild-type and mu-
tant huntingtin striatal cells. SKF 38393 treatment did not affect the
expression of the pro-fusion protein Opa1 neither in wild-type nor in
mutant huntingtin striatal cells (Fig. 6A) but induced a signiﬁcant in-
crease in total Drp1 levels (~1.3-fold increase and ~1.5-fold increase,
respectively; p b 0.05. Fig. 6B). Interestingly, the distribution of Drp1
within the subcellular compartments following dopaminergic activa-
tion was different between cell genotypes. Whereas in wild-type
cells the increase in Drp1 levels was found in the cytosolic fraction,
that in mutant huntingtin cells was located in the mitochondrial
fraction. Given the requirement of Drp1 translocation to the mitochon-
dria for the ﬁssion of this organelle [31,32], the aberrant distribution of
Drp1 in mutant huntingtin striatal cells may explain the increased
mitochondrial fragmentation observed in these cells compared to
wild-type cells. Next, we investigated whether dopaminergic stimuli
could also affect Drp1 enzymatic activity. An increasing trend, although
not signiﬁcant, in Drp1 activity was found in wild-type cells after SKF
38393 treatment (Fig. 6C). By contrast, a signiﬁcant increase (~8-fold
increase; p b 0.01. Fig. 6C) was detected in SKF 38393-treated mutant
huntingtin cells suggesting that D1 receptor activation exacerbates
Drp1-dependent mitochondrial ﬁssion events in ST111/111Q mutant
cells.3.7. Inhibition of Cdk5 prevents D1R-induced mitochondrial ﬁssion and
mitochondrial branching alterations in striatal cells
We have shown that Cdk5 contributes to mitochondrial fragmen-
tation in mutant ST111/111Q cells while D1R activation increases
mitochondrial ﬁssion. Interestingly, we have previously reported
[2] that aberrant Cdk5 activity mediates D1R-induced neurotoxicity
in mutant ST111/111Q striatal cells. Altogether, it prompted us to
investigate whether Cdk5 was also mediating the mitochondrial
dysfunction induced by dopaminergic D1R activation. To this aim,
wild-type and mutant huntingtin striatal cells were treated with
roscovitine prior to incubation with SKF 38393 and mitochondrial
morphology was analyzed by confocal microscopy (Fig. 7A and E).
Roscovitine treatment completely recovered SKF 38393-induced
mitochondrial branching alterations (Fig. 7B and F) and prevented
mitochondrial fragmentation, either mitochondrial number (Fig. 7C
and G) or percentage of cells with mitochondria fragmentation
(Fig. 7D and H) in both cell genotypes, pointing Cdk5 as a mediator
of D1R-induced mitochondrial ﬁssion. To further corroborate these
results, Cdk5 protein levels were knocked-down in wild-type and
mutant huntingtin striatal cells by using speciﬁc Cdk5 siRNAs and
mitochondria fragmentation was analyzed following D1R activation
(Fig. 8A and E). First, the efﬁciency of the Cdk5 siRNA to knock-
down Cdk5 levels was determined by Western blot analysis. A simi-
lar and a signiﬁcant decrease in Cdk5 levels was found in Cdk5 siRNA
transfected cells compared to those transfected with scramble siRNA
(~50% decrease; p b 0.01. Supplementary Fig. 6). Then, mitochondri-
al ﬁssion was analyzed. Genetic knock-down of Cdk5 completely
prevented the decrease in mitochondrial branching (Fig. 8B and
F) and the increase in mitochondrial fragmentation induced by SKF
38393 treatment in both wild-type ST7/7Q and mutant ST111/111Q
huntingtin striatal cells (Fig. 8C, D, G and H), strongly supporting a
role for Cdk5 in D1R-induced mitochondrial dysfunction in striatal
cells.
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Fig. 7. Cdk5 inhibition restores the mitochondrial network in SKF 38393 treated ST7/7Q wild-type and ST111/111Qmutant cells. (A, E) Representative confocal images showing the mi-
tochondrial morphology in wild-type ST7/7Q and mutant ST111/111Q cells treated with vehicle, SKF 38393 (60 μM), roscovitine (20 μM) or roscovitine + SKF 38393. Cells were stained
with anti-TOM20 (green), anti-phalloidin-TRITC (red) and Hoechst stain (blue); scale bar 20 μm. Bottom panels show enlargement of the boxed areas; scale bar 2 μm. (B and F) Bar his-
togram showing mitochondrial branching changes determined by the analysis of the Form Factor (FF) value in vehicle or treated wild-type ST7/7Q and mutant ST111/111Q cells. Data
represent mean ± SEM of 5 independent experiments in which 25–30 cells/condition were analyzed with ImageJ software. *p b 0.05 vs. vehicle-treated striatal cells and ###p b 0.001
vs. SKF 38393 treated cells as determined by One-way ANOVA with Newman–Keuls post hoc analysis. (C and G) Bar histograms showing the percentage of number of mitochondria
per cell. Data represent mean ± SEM of 5 independent experiments in which 25–30 cells/condition were analyzed with ImageJ software. *p b 0.05 vs. vehicle-treated striatal cells and
###p b 0.001 and #p b 0.05 vs. SKF 38393 treated cells as determined by One-way ANOVA with Newman–Keuls post hoc analysis. (D and H) Bar histograms showing the percentage of
vehicle or treated wild-type ST7/7Q and mutant ST111/111Q cells with fragmented mitochondria relative to the total number of cells. Data represent mean ± SEM of 5 independent ex-
periments inwhich 25–30 cells/conditionwere analyzedwith ImageJ software. *p b 0.05 vs. vehicle-treated striatal cells as determined by One-way ANOVAwith Newman–Keuls post hoc
analysis.
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Fig. 8. Inhibition of Cdk5 by Cdk5 siRNA prevents aberrant mitochondrial ﬁssion and altered branching induced by D1R activation in ST7/7Q wild-type and ST111/111Q mutant striatal
cells. (A and E) Representative confocal images showing the mitochondrial morphology in wild-type ST7/7Q and mutant ST111/111Q cells treated with vehicle or SKF 38393 (60 μM)
and transfected with siRNA or siCdk5 RNA. Cells were stained with anti-TOM20 (green), anti-Phalloidin-TRITC (red) and Hoechst stain (blue); scale bar 20 μm. Bottom panels show en-
largement of the boxed areas; scale bar 2 μm. (B and F) Bar histogram showingmitochondrial branching changes determined by the analysis of the Form Factor (FF) value in vehicle or SKF
38393 treated wild-type ST7/7Q and mutant ST111/111Q cells. Data represent mean ± SEM of 5 independent experiments in which 25–30 cells/condition were analyzed with ImageJ
software. *p b 0.05 vs. vehicle-treated siRNA-transfected striatal cells and #p b 0.05 vs. SKF 38393-treated siRNA-transfected cells as determined by One-way ANOVA with Newman–
Keuls post hoc analysis. (C and G) Bar histograms showing the percentage of number of mitochondria per cell. Data represent mean ± SEM of 5 independent experiments in which
25–30 cells/conditionwere analyzedwith ImageJ software. **p b 0.01 and *pb 0.05 vs. vehicle-treated siRNA-transfected striatal cells and ###p b 0.001 and ##p b 0.01 vs. SKF 38393-treated
siRNA-transfected cells as determined byOne-wayANOVAwith Newman–Keuls post hoc analysis. (D andH) Bar histograms showing the percentage of vehicle or SKF 38393 treatedwild-
type ST7/7Q andmutant ST111/111Q cells with fragmentedmitochondria relative to the total number of cells. Data representmean± SEM of 5 independent experiments inwhich 25–30
cells/condition were analyzed with ImageJ software. *p b 0.05 vs. vehicle-treated striatal cells as determined by One-way ANOVA with Newman–Keuls post hoc analysis.
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mitochondrial translocation of Drp1 in ST111/111Q striatal cells
We have demonstrated that mitochondrial fragmentation induced
by D1R activation was prevented by down-regulation of Cdk5while ac-
tivation of D1R induced an increase in the levels of the ﬁssion protein
Drp1. Hence, we analyzed whether mitochondrial ﬁssion induced by
D1R activation was mediated by a Cdk5-dependent increase in Drp1
function. Wild-type ST7/7Q and mutant ST111/111Q cells were
transfected with scramble or Cdk5 siRNA, treated with vehicle or SKF
38393 and levels of Drp1 were determined by Western blot analysis
(Fig. 9A).We found that reduction of Cdk5 expression prevented the ab-
normal increase of Drp1 caused by dopaminergic activation in both cell
genotypes (Fig. 9B). Since we previously demonstrated in mutant
huntingtin cells (Fig. 6) that D1R activation induces an increase inmito-
chondrial Drp1, we evaluated whether aberrant Cdk5 activity could be
responsible of SKF 38393-induced Drp1 mitochondrial enrichment.
Consistent with this idea, we found that mitochondrial Drp1 accumula-
tion in mutant huntingtin striatal cells was completely prevented by
inhibition of Cdk5 with roscovitine (Fig. 9C), suggesting that Cdk5 me-
diates D1 receptor-induced mitochondrial fragmentation by modula-
tion of Drp1 protein levels and distribution.
4. Discussion
Mitochondria are essential organelles for neuronal function and
survival given the prominent dependence of neuronal cells on mito-
chondrial ATP production to support different functions including
membrane potentialmaintenance, neurotransmitter release and uptake
or transportation of synaptic vesicles [33]. In HD the most important
neuropathological alteration is the preferential loss of medium spiny
neurons within the striatum [9]. Though the precise molecular mecha-
nisms leading to this speciﬁc cell death are unknown, growing evidence
have emerged for impairedmitochondrial function as a causative factor
[34,35]. In this view, here, we have reported in a precise genetic HD
striatal cell line and in HD striatal cell cultures impaired mitochondrial
dynamics manifested as higher mitochondrial fragmentation and de-
creased mitochondrial branching compared to wild-type striatal cells,
which is consistent with previous studies reporting, in different HD
models, altered levels of ﬁssion/fusion proteins and increased mito-
chondrial ﬁssion [17,24,36]. Surprisingly, enhanced mitochondrial frag-
mentation inmutant huntingtin striatal cells was not associatedwith an
increase in the levels of the ﬁssion protein Drp1, neither at the total nor
at the mitochondrial level, but with a decrease. Importantly, the de-
crease in Drp1 protein levels in mutant huntingtin cells was associated
with lower Drp1 mRNA expression suggesting that mHtt may alter mi-
tochondrial dynamics by acting on transcriptional regulation of Drp1. In
this view, it has been described that p53 is an important modulator of
mitochondrial ﬁssion by transcriptional regulation of Drp1 expres-
sion [37]. Interestingly, previous works have demonstrated reduced
p53-mediated gene transcription in mutant huntingtin expressing
cells suggesting that the decrease in Drp1mRNA levels found inmutant
striatal cells could be related with a deﬁcient p53 transcriptional
function [38].
If the levels and expression of Drp1 are low in mutant huntingtin
striatal cells, one intriguing question is how mitochondrial fragmenta-
tion can be enhanced in these cells. Interestingly, we found that the
GTPase activity of Drp1, that is critical for mitochondrial fragmentation,
was signiﬁcantly higher in mutant huntingtin striatal cell lines and in
the striatumof HDknock-inmutantmice indicating that in the presence
ofmHtt, the activity of Drp1 is aberrantly activated. Theseﬁndings are in
agreement with previous studies showing elevated Drp1 activity in the
striatum and cortex of BACHD mice and in the cortex of HD patients
[39]. Importantly, besides an increase in Drp1 activity a decrease in
the levels of the fusion protein Opa1was also observed suggesting alto-
gether, that an imbalance in the levels and activity of proteins involvedin the mitochondrial dynamic machinery could be responsible for the
abnormal mitochondrial morphology observed in mutant huntingtin
cells.
How these changes in mitochondrial dynamics may contribute
to increasing susceptibility of mutant huntingtin striatal cells to neu-
rodegeneration? Oxidative stress as a consequence of dopamine me-
tabolism results in the formation of reactive oxidative species and
quinones that may affect several mitochondrial processes such as ATP
production, membrane permeability or ﬁssion/fusion mitochondrial
events [40–42]. Indeed, mitochondrial respiration and ATP production
are signiﬁcantly reduced in our HD striatal cell lines along with an in-
crease in mitochondrial-generated reactive-oxidative species and a de-
crease in the mitochondrial membrane potential [43–46]. However,
dopamine besides being an inductor of oxidative stress can also induce
mitochondrial dysfunction through activation of dopamine receptors.
Actually, activation of dopamine D2 receptors in mutant huntingtin
striatal neurons alters mitochondrial function by down-regulating mi-
tochondrial complex II expression [18] while mitochondrial axonal
transport can be regulated by integration of the opposite effects of
D1R and D2R activation [47]. Notably, there is no data on the potential
role of dopamine receptors in mitochondrial ﬁssion-fusion events. In
the present manuscript, we describe for the ﬁrst time that D1R activa-
tion induces mitochondrial dynamics defects, leading to a percentage
of striatal cells displaying mitochondrial fragmentation close to 80%
whenmHtt is expressed and to 40% in wild type conditions. Themolec-
ular mechanism underlying D1R-induced mitochondrial fragmentation
either in wild-type or mutant huntingtin striatal cells involves an in-
crease in Drp1 protein levels. However, two major differences can be
noticed when mutant and wild-type cells are compared. First, in wild-
type cells the increase in Drp1 levels was located in the cytosolic frac-
tion while that in mutant huntingtin cells was found in the mitochon-
dria and second, in mutant but not wild-type huntingtin cells the
increase in Drp1 protein levels was accompanied by an increase in
their GTPase activity, which agrees with the data on mitochondrial
Drp1 localization. Altogether, these data suggest that D1R activation in-
creases mHtt-induced mitochondrial fragmentation by altering Drp1
activity, which may be related with the higher susceptibility of mutant
huntingtin striatal cells to D1R activation.
How D1R activation induces such changes in Drp1 levels, distribu-
tion and activity is a crucial question. Previous studies from our group
have demonstrated that the increase in cell death induced by D1R acti-
vation in mutant huntingtin striatal cells is related with an increase in
the activity of the Ser/Thr kinase Cdk5 [2]. Interestingly, Cdk5 has
been involved in mitochondrial dysfunction by increasing oxidative
stress [28] or acting as an upstream regulator ofmitochondrial fragmen-
tation [21]. In this scenario,we tried to integrate both pathways hypoth-
esizing that in mutant huntingtin striatal cells the increase in Cdk5
activity induced by D1R activation was responsible for the increase in
mitochondrial fragmentation. Supporting this hypothesis our data dem-
onstrates that (1) inhibition of Cdk5 reducesDrp1 activity inmutant cells
to levels similar to those found in wild-type cells, which was associated
with a signiﬁcant decrease in mitochondrial fragmentation and (2) pre-
vents inmutant huntingtin cells the D1R-mediated increase of Drp1 pro-
tein levels and their translocation to the mitochondria. Translocation of
Drp1 to the mitochondria is a critical event in mitochondrial fragmenta-
tion [48]. Even though the precise mechanisms underlying the recruit-
ment of Drp1 to the mitochondria surface are not well understood
several studies stress the role of Drp1 post-translational modiﬁcations
[49]. Regarding regulation of Drp1 activity by phosphorylation the pub-
lished data can be rather confusing, since phosphorylation at the same
residuemay result in induction or prevention ofmitochondrial ﬁssion de-
pending on cell type, physiological/pathological condition or even the ki-
nase involved [50]. This is the case for Ser616. While in post-mitotic
mature neurons and in physiological conditions phosphorylation at
Ser616 by Cdk5 inhibits Drp1 activity and thereforemitochondrial ﬁssion
[51], under pathological conditions, Ser616 (or Ser579 in Drp1 isoform
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Fig. 9. Cdk5 promotesmitochondrial ﬁssion by altering the levels and the distribution of Drp1 in SKF 38393 treated ST111/111Qmutant cells. (A) RepresentativeWestern blots showing the
levels of theﬁssion proteinDrp1 and Cdk5 in total extracts obtained from siRNAor siCdk5 transfectedwild-type ST7/7Q andmutant ST111/111Q cells.α-Tubulinwas used as loading control.
When indicated, cellswere treatedwith SKF38393 (60 μM)during1h. Letters confer to the different isoforms recognized by the respective antibody (DRP1: a–b). (B) Bar histograms showing
the relative fold changeof Cdk5 andDrp1protein levels inwild-type ST7/7Q andmutant ST111/111Q cells. Data representmean±SEMof 6 independent experiments. ***pb 0.001, **pb 0.01
vs. vehicle-treated siRNA transfected ST7/7Q cells, ###p b 0.001 vs. vehicle-treated siCdk5 transfected ST7/7Q cells, §§§p b 0.001 and §§p b 0.01 vs. vehicle-treated siRNA transfected ST111/
111Q cells as determined by One-way ANOVAwith Newman–Keuls post hoc analysis. (C) RepresentativeWestern blots showing the levels of the ﬁssion protein Drp1 inmitochondrial frac-
tions obtained from vehicle or roscovitine treatedmutant ST111/111Q cells.When indicated, cells were treatedwith SKF 38393 (60 μM)during 1 h. CoxVwas used as loading control. Letters
indicate the different isoforms recognizedby the respective antibody (DRP1: a–b). Bar histogram indicates the relative fold change±SEMof 6 independentexperiments; *pb 0.05 vs. vehicle-
treated ST111/111Q cells and ##p b 0.01 vs. roscovitine-treated ST111/111Q cells as determined by One-way ANOVAwith Newman–Keuls post hoc analysis.
2158 M. Cherubini et al. / Biochimica et Biophysica Acta 1852 (2015) 2145–21603) promotes mitochondrial ﬁssion either in mitotic or neuronal cells
[52–54]. In our study, however, we have not observed any increase in
phosphorylation at Ser616 in HD striatal cells compared to wild type
cells (Supplementary Fig. 7) although Drp1 activity has been found to be
increased suggesting that phosphorylation in other residues or other post-
translational modiﬁcations could be involved. In this view, several studies
have pointed out the role of the actin and microtubule cytoskeleton in
Drp1-induced mitochondrial ﬁssion [48,55,56]. Interestingly, Cdk5 can
phosphorylate a plethora of different proteins involved in cytoskeleton dy-
namics [57,58]. Indeed, increased Tau phosphorylation has been previously
reported inmutant huntingtin striatal cells by our group [2] suggesting thatan aberrant phosphorylation of cytoskeleton-related proteins could be in-
volved in the accumulation of Drp1 in the mitochondria of mutant
huntingtin striatal cells leading to mitochondrial ﬁssion.
5. Conclusion
In conclusion, we propose a model in which increased Cdk5 activity
induced by both mHtt expression and aberrant dopaminergic signaling
would contribute to increasing striatal susceptibility in HD by altering
the expression, distribution and activity of Drp1 leading tomitochondri-
al ﬁssion events. Thus, our study contributes to the understanding of
2159M. Cherubini et al. / Biochimica et Biophysica Acta 1852 (2015) 2145–2160the molecular mechanisms underlying striatal neurotoxicity in HD sug-
gesting an important link between Cdk5 and Drp1 as mediators of
dopaminergic-inducedmitochondrial fragmentation in neurodegenera-
tive diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.06.025.
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